Inhibiting the DNA damage response as a therapeutic manoeuvre in cancer
Author:
Affiliation:
1. Northern Institute for Cancer Research; Medical School; Newcastle University; Newcastle upon Tyne; UK
Publisher
Wiley
Subject
Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.12244/fullpdf
Reference228 articles.
1. Human AP endonuclease 1 (APE1): from mechanistic insights to druggable target in cancer;Abbotts;Cancer Treat Rev,2010
2. XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining;Ahnesorg;Cell,2006
3. Ataxia-telangiectasia-mutated (ATM) gene in head and neck squamous cell carcinoma: promoter hypermethylation with clinical correlation in 100 cases;Ai;Cancer Epidemiol Biomarkers Prev,2004
4. Inhibition of poly(ADP-ribose) polymerase enhances cell death and improves tumor growth delay in irradiated lung cancer models;Albert;Clin Cancer Res,2007
5. Vasoactivity of AG014699, a clinically active small molecule inhibitor of poly(ADP-ribose) polymerase: a contributory factor to chemopotentiation in vivo?;Ali;Clin Cancer Res,2009
Cited by 61 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. DNA damage response-related ncRNAs as regulators of therapy resistance in cancer;Frontiers in Pharmacology;2024-08-26
2. Spatial-temporal-controlled NO gas and PARP1 siRNA delivery for alleviating the dilemma of deeper sonodynamic therapy in pancreatic cancer;Chemical Engineering Journal;2024-06
3. Integration of scRNA and bulk RNA-sequence to construct the 5-gene molecular prognostic model based on the heterogeneity of thyroid carcinoma endothelial cell;Acta Biochimica et Biophysica Sinica;2024-01-01
4. Usnic Acid Derivatives Inhibit DNA Repair Enzymes Tyrosyl-DNA Phosphodiesterases 1 and 2 and Act as Potential Anticancer Agents;Genes;2023-10-12
5. The Promise of Nanoparticles-Based Radiotherapy in Cancer Treatment;Cancers;2023-03-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3